Canaccord Adams initiates coverage on Cynosure (Nasdaq: CYNO) with a Buy. Price target $17.25.

Canaccord analyst says, "Cynosure’s SmartLipo opportunity ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE